Antibody formation and its impact on long-term graft outcome

Transplant Proc. 2001 May;33(3):2411-3. doi: 10.1016/s0041-1345(01)02056-5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody Formation*
  • Cells, Cultured
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / immunology
  • Endothelium, Vascular / physiology*
  • Graft Survival / immunology
  • Graft Survival / physiology*
  • HLA-A1 Antigen / immunology*
  • HLA-A2 Antigen / immunology*
  • Humans
  • Immunoglobulin G / immunology*
  • Immunoglobulin G / pharmacology
  • Immunosuppressive Agents / therapeutic use
  • Isoantibodies / immunology
  • Isoantibodies / pharmacology
  • NF-kappa B / metabolism
  • T-Lymphocytes / immunology
  • Time Factors
  • Transplantation Immunology*
  • Treatment Outcome
  • Umbilical Veins

Substances

  • HLA-A1 Antigen
  • HLA-A2 Antigen
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Isoantibodies
  • NF-kappa B